Primary cardiac tumors.
From 1970 to 1986, 3 males and 6 females, ranging in age from 13 to 69 years (median 45 years), underwent heart surgery for a primary cardiac tumor. Six patients had a left atrial myxoma; a lipofibroma, a lymphosarcoma and a rhabdomyosarcoma were found each in 1 patient. The following complaints were present: congestive heart failure in 8, fatigue in 7, cardiac arrhythmia in 3, palpitations in 3, fever in 2 and finally weight loss, nocturnal perspiration and clubbing were each in one patient. The duration of symptoms ranged from 6 weeks to more than 2 years (median 10.8 months). All patients were operated with the aid of extracorporeal circulation as soon as they were diagnosed. One patient with extensive tumor growth died at the end of the procedure. During the follow-up period all patients with a primary malignant tumor died within 3 months. Those with myxoma or fibroma are still alive with a follow-up period extending to 13 years (median 7 years). All surviving patients are asymptomatic and well. Malignant cardiac tumors do have a very poor prognosis, they are only amenable for palliative resection and even then prognosis remains poor. When an endocardial biopsy confirms the diagnosis of a cardiac malignancy, the indication for operation is questionable, although there is an absolute indication in case of obstruction. Cardiac myxoma should be resected after diagnosis because the potential embolic complications may be debilitating or lethal. The operative risk is small, and the long term results are excellent.
Van de Wal
H J
HJ
Department Thoracic and Cardiac Surgery, Sint Radboud University Hospital, Nijmegen, The Netherlands.
Fritschy
W M
WM
Skotnicki
S H
SH
Lacquet
L K
LK
D000293:Adolescent; D000328:Adult; D000368:Aged; D005112:Extracorporeal Circulation; D005260:Female; D005350:Fibroma / Q000601:surgery; D006338:Heart Neoplasms / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008224:Lymphoma, Follicular / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009232:Myxoma / Q000601:surgery*; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000601:surgery